Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-06 4:31 pm Purchase |
2025-02-27 | 13G | DarioHealth Corp. DRIO |
Nantahala Capital Partners Limited Partnership | 2,511,120 5.777% |
2,511,120 (New Position) |
Filing History |
| 2025-02-19 4:32 pm Purchase |
2025-02-16 | 13G | Eagle Pharmaceuticals, Inc. EGRX |
Nantahala Capital Partners Limited Partnership | 810,630 6.241% |
810,630 (New Position) |
Filing History |
| 2025-02-14 4:31 pm Purchase |
2024-12-02 | 13G | Senti Biosciences, Inc. SNTI |
Nantahala Capital Partners Limited Partnership | 301,500 5.914% |
301,500 (New Position) |
Filing History |
| 2024-12-20 4:31 pm Sale |
2024-12-19 | 13G | Unicycive Therapeutics, Inc. UNCY |
Nantahala Capital Partners Limited Partnership | 3,009,021 2.760% |
-4,878,815 (-61.85%) |
Filing History |
| 2024-12-04 4:31 pm Purchase |
2024-11-27 | 13G | InspireMD, Inc. NSPR |
Nantahala Capital Partners Limited Partnership | 1,411,636 5.220% |
1,411,636 (New Position) |
Filing History |
| 2024-11-14 4:53 pm Purchase |
2024-09-30 | 13G | Surrozen, Inc. SRZN |
Nantahala Capital Partners Limited Partnership | 176,970 5.280% |
176,970 (New Position) |
Filing History |
| 2024-11-14 4:53 pm Purchase |
2024-09-30 | 13G | Unicycive Therapeutics, Inc. UNCY |
Nantahala Capital Partners Limited Partnership | 7,887,836 7.760% |
5,766,083 (+271.76%) |
Filing History |
| 2024-02-02 8:32 pm Purchase |
2023-09-29 | 13G | Unicycive Therapeutics, Inc. UNCY |
Nantahala Capital Partners Limited Partnership | 2,121,753 6.100% |
2,121,753 (New Position) |
Filing History |